About our promoted products: Our 'promoted' products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you. Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment
|52-week range||USD$1.08 - USD$17.15|
|50-day moving average||USD$8.7621|
|200-day moving average||USD$7.102|
|Wall St. target price||USD$17.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.033|
|1 week (2021-02-21)||N/A|
|1 month (2021-01-31)||N/A|
|3 months (2020-11-30)||N/A|
|6 months (2020-08-31)||N/A|
|1 year (2020-02-29)||N/A|
|2 years (2019-02-28)||N/A|
|3 years (2018-02-28)||N/A|
|5 years (2016-02-29)||N/A|
There are currently 27.5 million Vaxart shares held short by investors – that's known as Vaxart's "short interest". This figure is 10.3% down from 30.7 million last month.
There are a few different ways that this level of interest in shorting Vaxart shares can be evaluated.
Vaxart's "short interest ratio" (SIR) is the quantity of Vaxart shares currently shorted divided by the average quantity of Vaxart shares traded daily (recently around 27.8 million). Vaxart's SIR currently stands at 0.99. In other words for every 100,000 Vaxart shares traded daily on the market, roughly 990 shares are currently held short.
However Vaxart's short interest can also be evaluated against the total number of Vaxart shares, or, against the total number of tradable Vaxart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaxart's short interest could be expressed as 0.25% of the outstanding shares (for every 100,000 Vaxart shares in existence, roughly 250 shares are currently held short) or 0.3293% of the tradable shares (for every 100,000 tradable Vaxart shares, roughly 329 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vaxart.
Steps to owning and managing Antero Resources shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Aphria shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Churchill Capital Corp IV shares, with 24-hour and historical pricing before you buy.
All the key details you need to know to buy THL shares on the NZX.
The steps you need to take to buy Port of Tauranga shares on the NZX.
We’ll show you what you need to do to buy Arvida shares on the New Zealand Stock Exchange.
Your simple how-to guide if you want to buy Mainfreight shares on the NZX.
Steps to owning and managing Bed Bath & Beyond shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Forte Biosciences shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Blockbuster shares, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.